Dr Philip Shackley
| Exiting Surveillance From Abdominal Aortic Aneurysm Screening: The Views of Clinicians, and Men in Surveillance and Their Family Members | 2025 |
|
Professor Richard Walker
Dr Philip Shackley
| The cost of treating stroke in urban and rural Tanzania: A 6 month pilot study. | 2013 |
|
Dr Philip Shackley
Dr Lisa Shaw
Dr Christopher Price
Professor Michael Barnes
Dr Laura Graham
et al. | Cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin A: results from the botulinum toxin for the upper limb after stroke (BoTULS) trial | 2012 |
|
Dr Lisa Shaw
Dr Christopher Price
Frederike Van Wijck
Dr Philip Shackley
Dr Nick Steen
et al. | Botulinum Toxin for the Upper Limb After Stroke (BoTULS) Trial: Effect on Impairment, Activity Limitation, and Pain | 2011 |
|
Professor Cam Donaldson
Dr Rachel Baker
Dr Helen Mason
Emeritus Professor Michael Jones-Lee
Dr Emily Lancsar
et al. | The social value of a QALY: raising the bar or barring the raise? | 2011 |
|
Dr Lisa Shaw
Emerita Professor Helen Rodgers
Dr Christopher Price
Dr Philip Shackley
Dr Nick Steen
et al. | BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A | 2010 |
|
Dr Rachel Baker
Professor Cam Donaldson
Emeritus Professor Michael Jones-Lee
Dr Emily Lancsar
Professor Graham Loomes
et al. | Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project | 2010 |
|
Dr Mark Pennington
Professor Chris Vernazza
Dr Philip Shackley
Nigel Armstrong
Professor John Whitworth
et al. | Evaluation of the cost-effectiveness of root canal treatment using conventional approaches versus replacement with an implant | 2009 |
|
Emerita Professor Helen Rodgers
Dr Lisa Shaw
Dr Christopher Price
Martine Barnes
Dr Laura Graham
et al. | Study design and methods of the BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A | 2008 |
|
Professor Cam Donaldson
Dr Rachel Baker
Emeritus Professor Michael Jones-Lee
Dr Emily Lancsar
Professor Graham Loomes
et al. | Weighting and valuing quality adjusted life years: preliminary results from the social value of a QALY project | 2008 |
|
Dr Philip Shackley
Emeritus Professor Jimmy Steele CBE
| A comparison of the ‘cost per child treated’ at a primary care-based sedation referral service, compared to a general anaesthetic in hospital | 2007 |
|
Rachel Appleton
Julie Doughty
Dr Ann Jacoby
Dr Philip Shackley
Alessandra Vanoli
| A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial | 2007 |
|
Julie Doughty
Dr Margaret Jackson
Dr Ann Jacoby
Dr Geoff Lawson
Dr Philip Shackley
et al. | Carbamazepine versus gabapentin, lamotrigine, oxcarbazepine or topiramate for partial epilepsy: results from Arm A of the SANAD Trial | 2007 |
|
Dr Nigel Cooper
Julie Doughty
Dr Geoff Lawson
Dr Philip Shackley
Dr Jing Shen
et al. | The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial | 2007 |
|
Dr Nigel Cooper
Julie Doughty
Dr Margaret Jackson
Dr Ann Jacoby
Dr Geoff Lawson
et al. | The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial | 2007 |
|
